changes in clinical trials methodology over time a systematic review of six decades of research in psychopharmacology临床试验方法的变化随着时间的推移系统回顾60年的精神药理学研究.pdfVIP
- 1
- 0
- 约11.01万字
- 约 16页
- 2017-08-31 发布于上海
- 举报
changes in clinical trials methodology over time a systematic review of six decades of research in psychopharmacology临床试验方法的变化随着时间的推移系统回顾60年的精神药理学研究
Changes in Clinical Trials Methodology Over Time: A
Systematic Review of Six Decades of Research in
Psychopharmacology
´ 1 2,3 3
Andre R. Brunoni , Laura Tadini , Felipe Fregni *
1 Department and Institute of Psychiatry, University of Sao Paulo, Sao Paulo, Brazil, 2 Centro Clinico per le Neuronanotecnologie e la Neurostimolazione, Fondazione
IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy, 3 Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical
Center, Harvard Medical School, Boston, Massachusetts, United States of America
Abstract
Background: There have been many changes in clinical trials methodology since the introduction of lithium and the
beginning of the modern era of psychopharmacology in 1949. The nature and importance of these changes have not been
fully addressed to date. As methodological flaws in trials can lead to false-negative or false-positive results, the objective of
our study was to evaluate the impact of methodological changes in psychopharmacology clinical research over the past 60
years.
Methodology/Principal Findings: We performed a systematic review from 1949 to 2009 on MEDLINE and Web of Science
electronic databases, and a hand search of high impact journals on studies of seven major drugs (chlorpromazine, clozapine,
risperidone, lithium, fluoxetine and lamotrigine). All controlled studies published 100 months after the first trial were
included. Ninety-one studies met our inclusion criteria. We analyzed the major changes in abstract reporting, study design,
participants’ assessment and enrollment, methodology and statistical analysis. Our results showed that the methodology of
psychiatric clinical trials changed substantially, with quality gains in abstract reporting,
您可能关注的文档
- cancer incidence among adolescents and young adults in urban shanghai, 1973–2005癌症发病率在青少年和年轻人在城市上海,1973 - 2005.pdf
- cancer reduces transcriptome specialization癌症减少转录组专业化.pdf
- cancer risk associated with insulin glargine among adult type 2 diabetes patients – a nationwide cohort study癌症风险与成人2型糖尿病患者胰岛素u2014u2014一个全国性的队列研究.pdf
- cancer risk of anti-tnf-α at recommended doses in adult rheumatoid arthritis a meta-analysis with intention to treat and per protocol analyses癌症的风险在推荐剂量anti-tnf-α成人类风湿性关节炎与意图治疗分析和协议分析.pdf
- cancer risk in diabetic patients treated with metformin a systematic review and meta-analysis癌症风险与二甲双胍治疗糖尿病患者的系统回顾和荟萃分析.pdf
- cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts癌细胞的表达autotaxin控制骨转移形成鼠标通过lysophosphatidic acid-dependent激活破骨细胞.pdf
- cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-raf-1癌症基因组学标识监管相关基因网络从发育不良过渡到高级c-raf-1引起的肺腺癌.pdf
- cancer-associated splicing variant of tumor suppressor aimp2p38 pathological implication in tumorigenesis癌症相关的肿瘤抑制的剪接变体aimp2p38病理肿瘤发生的影响.pdf
- cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4t1 murine breast cancer model肿瘤相关成纤维细胞促进肿瘤的生长和转移通过调节肿瘤免疫微环境4 t1乳腺癌小鼠模型.pdf
- cancer cells acquire mitotic drug resistance properties through beta i-tubulin mutations and alterations in the expression of beta-tubulin isotypes肿瘤细胞耐药性获得有丝分裂属性通过βi-tubulin突变和改变的表达beta-tubulin同形像.pdf
原创力文档

文档评论(0)